Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Gynecol Endocrinol ; 33(3): 185-187, 2017 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-28102088

RESUMO

Most frequent causes of androgenic manifestation are Cushing's syndrome, PCO, benign and malignant androgen-secreting non adrenal tumors and iatrogenic hirsutism. Hyperplasia or neoplasms of ectopic adrenocortical gland are rare. We report a case of a 63-year old female with hirsutism and alopecia. Laboratory data highlighted increased levels of androgens. Diagnostic imaging revealed normal morphology of adrenocortical gland and ovaries. In view of the clinical picture and suspected diagnosis of extra-adrenal cause, she underwent bilateral salpingo-oophorectomy. Histologic examination showed an ectopic adrenal gland with adenoma in the ovarian and peri-ovarian tissue. At six months of follow up, the patients has no sign of hyperandrogenism. In case of hyperandrogenism in postmenopausal women and in the absence of the adrenocortical gland abnormality, ovarian origin should be considered in the differential diagnosis.


Assuntos
Adenoma/diagnóstico , Hiperandrogenismo/etiologia , Neoplasias Ovarianas/diagnóstico , Adenoma/patologia , Adenoma/fisiopatologia , Adenoma/cirurgia , Alopecia/etiologia , Alopecia/prevenção & controle , Diagnóstico Diferencial , Feminino , Hirsutismo/etiologia , Hirsutismo/prevenção & controle , Humanos , Hiperandrogenismo/fisiopatologia , Hiperandrogenismo/prevenção & controle , Pessoa de Meia-Idade , Neoplasias Ovarianas/patologia , Neoplasias Ovarianas/fisiopatologia , Neoplasias Ovarianas/cirurgia , Ovariectomia , Cidade de Roma , Salpingectomia , Resultado do Tratamento
2.
Int J Clin Exp Pathol ; 8(6): 7610-3, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26261678

RESUMO

INTRODUCTION: Tamoxifen is the usual endocrine (anti-estrogen) therapy for hormone receptor-positive breast cancer in pre and post-menopausal women. Previous studies have suggested an increased prevalence of endometrial diseases after treatment with tamoxifen. CASE PRESENTATION: The authors report a case of 38-year-old woman with diagnosis of endometrial polyp and tubal metaplasia, during puerperium and after micropapillary ductal breast cancer surgery, 5 years of tamoxifen treatment, spontaneous pregnancy without complications and full-term vaginal delivery. CONCLUSION: Tamoxifen is a safe and reliable treatment of breast cancer, but data suggest an association with endometrial polyps, hyperplasia, metaplasia and carcinoma. One of the most common types of endometrial metaplasia is ciliated tubal metaplasia. It is generally known that endometrial tubal metaplasia is a benign disease. However studies propose endometrial tubal metaplasia to be a potential premalignant endometrial lesion and its association with endometrial hyperplasia and well-differentiated endometrioid carcinoma. We propose close monitoring of patients taking tamoxifen and prompt evaluation of any uterine bleeding or pelvic complaint or abnormal TVUS images.


Assuntos
Antineoplásicos Hormonais/efeitos adversos , Neoplasias da Mama/tratamento farmacológico , Hiperplasia Endometrial/induzido quimicamente , Endométrio/efeitos dos fármacos , Doenças das Tubas Uterinas/induzido quimicamente , Tubas Uterinas/efeitos dos fármacos , Pólipos/induzido quimicamente , Período Pós-Parto , Tamoxifeno/efeitos adversos , Adulto , Neoplasias da Mama/patologia , Neoplasias da Mama/cirurgia , Quimioterapia Adjuvante , Hiperplasia Endometrial/patologia , Hiperplasia Endometrial/cirurgia , Endométrio/patologia , Endométrio/cirurgia , Doenças das Tubas Uterinas/patologia , Doenças das Tubas Uterinas/cirurgia , Tubas Uterinas/patologia , Tubas Uterinas/cirurgia , Feminino , Humanos , Histeroscopia , Mastectomia , Metaplasia , Pólipos/patologia , Pólipos/cirurgia , Gravidez , Fatores de Tempo , Resultado do Tratamento
3.
Reprod Biol Endocrinol ; 12: 37, 2014 May 09.
Artigo em Inglês | MEDLINE | ID: mdl-24886252

RESUMO

Bisphenol A (BPA) is a high production volume monomer used for making a wide variety of polycarbonate plastics and resins. A large body of evidence links BPA to endocrine disruption in laboratory animals, and a growing number of epidemiological studies support a link with health disorders in humans. The aim of this review is to summarize the recent experimental studies describing the effects and mechanisms of BPA on the female genital tract and to compare them to the current knowledge regarding the impact of BPA impact on female reproductive health. In particular, BPA has been correlated with alterations in hypothalamic-pituitary hormonal production, reduced oocyte quality due to perinatal and adulthood exposure, defective uterine receptivity and the pathogenesis of polycystic ovary syndrome. Researchers have reported conflicting results regarding the effect of BPA on premature puberty and endometriosis development. Experimental studies suggest that BPA's mechanism of action is related to life stage and that its effect on the female reproductive system may involve agonism with estrogen nuclear receptors as well as other mechanisms (steroid biosynthesis inhibition). Notwithstanding uncertainties and knowledge gaps, the available evidence should be seen as a sufficient grounds to take precautionary actions against excess exposure to BPA.


Assuntos
Compostos Benzidrílicos/toxicidade , Disruptores Endócrinos/toxicidade , Medicina Baseada em Evidências , Genitália Feminina/efeitos dos fármacos , Fenóis/toxicidade , Plastificantes/toxicidade , Animais , Endometriose/induzido quimicamente , Endometriose/patologia , Feminino , Genitália Feminina/patologia , Humanos , Sistema Hipotálamo-Hipofisário/efeitos dos fármacos , Sistema Hipotálamo-Hipofisário/patologia , Ovário/efeitos dos fármacos , Ovário/patologia , Síndrome do Ovário Policístico/induzido quimicamente , Síndrome do Ovário Policístico/patologia , Desenvolvimento Sexual/efeitos dos fármacos , Útero/efeitos dos fármacos , Útero/patologia
4.
J Ovarian Res ; 6(1): 46, 2013 Jul 04.
Artigo em Inglês | MEDLINE | ID: mdl-23826666

RESUMO

Primary non-Hodgkin's lymphoma of the ovary is a rare occurrence. An ovarian involvement by non-Hodgkin lymphoma (NHL) may include one of the four subtypes of lymphoma: diffuse large B-cell lymphoma, Burkitt's lymphoma (BL), lymphoblastic lymphoma or anaplastic large cell lymphoma. Burkitt's lymphoma is a rare entity with a specific poorly differentiated pattern.Most women experience an ovarian BL with abdominal pelvic pain, abnormal vaginal bleeding, bowel obstruction, urinary frequency, incontinence and abdominal mass. Sometimes these warning signs may be absent, causing a late and more difficult diagnosis.Here we report a case of a primary ovarian Burkitt's lymphoma with bilateral involvement in a 57 year old patient. She firstly presented neurological symptoms in the upper limbs and she was treated with surgery and combined chemotherapy. The diagnosis of malignant lymphoma was established after bilateral adnexectomy and histological study of the excised tissue.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...